Arrowhead Pharmaceuticals, Inc. (ARWR)
64.52
-0.12
(-0.19%)
USD |
NASDAQ |
Feb 06, 16:00
64.57
+0.05
(+0.08%)
After-Hours: 20:00
Arrowhead Pharmaceuticals SG&A Expense (TTM) : 143.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 527.29M |
| Eli Lilly & Co. | 11.09B |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Sanofi | 10.80B |
| Cidara Therapeutics, Inc. | 28.09M |